Aligos Therapeutics has been focused on protecting inventions in United States(US) with ten publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 62% filings and 100% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Aligos Therapeutics is filings its patents. Among the top granted patent authorities, Aligos Therapeutics has 100% of its grants in United States(US)
Johnson & Johnson and F. Hoffmann-La Roche could be the strongest competitors for Aligos Therapeutics
Patents related to rare diseases lead Aligos Therapeutics’s portfolio
Aligos Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.
Hepatitis b related patents lead Aligos Therapeutics portfolio followed by hepatitis d, and cardiovascular disease
Aligos Therapeutics has highest number of patents in hepatitis b followed by hepatitis d, cardiovascular disease, atherosclerosis, and obsessive-compulsive disorder. For hepatitis b, nearly 54% of patents were filed and 8% of patents were granted in Q4 2023.
For comprehensive analysis of Aligos Therapeutics‘s filings and grants, buy the databook here.
From 
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.